Lyssenko V, Eliasson L, Kotova O, Pilgaard K, Wierup N, Salehi A, Wendt A, Jonsson A, De Marinis YZ, Berglund LM, Taneera J, Balhuizen A, Hansson O, Osmark P, Dunér P, Brøns C, Stančáková A, Kuusisto J, Bugliani M, Saxena R, Ahlqvist E, Kieffer TJ, Tuomi T, Isomaa B, Melander O, Sonestedt E, Orho-Melander M, Nilsson P, Bonetti S, Bonadonna R, Miccoli R, DelPrato S, Marchetti P, Madsbad S, Poulsen P, Vaag A, Laakso M, Gomez MF, Groop L. Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes 2011;60:2424–2433
In the research design and methods section in the print version of the article listed above, GLP-1 and GIP infusion concentrations have reverse order as compared to the original publication (ref. 22). The correct order is as follows: “At t = −2 min, a bolus of either GLP-1 or GIP was infused to increase the plasma concentration to approximately 120 and 1,000 pmol/L, respectively. At t = 0 min, a continuous infusion of GLP-1 or GIP (60 or 240 pmol/kg ⋅ h, respectively) was initiated and terminated at t = 120 min.” The online version reflects these changes.
